These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8887448)

  • 1. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):233-9. PubMed ID: 8209376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
    Conway JG; Neptun DA; Garvey LK; Popp JA
    Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferators activate Kupffer cells in vivo.
    Bojes HK; Thurman RG
    Cancer Res; 1996 Jan; 56(1):1-4. PubMed ID: 8548746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
    Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL
    Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS; Cattley RC; Conway JG; Popp JA
    Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical increase in peroxisomal cyanide-insensitive respiration following dietary exposure to WY-14,643 in the perfused liver.
    Bojes HK; Sausen PJ; Cattley RC; Keller BJ; Thurman RG
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):202-9. PubMed ID: 8661345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-induction by peroxisome proliferators of microsomal 1-acylglycerophosphocholine acyltransferase with peroxisomal beta-oxidation in rat liver.
    Kawashima Y; Horii S; Matsunaga T; Hirose A; Adachi T; Kozuka H
    Biochim Biophys Acta; 1989 Sep; 1005(2):123-9. PubMed ID: 2570610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
    Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
    Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
    Watanabe T; Lalwani ND; Reddy JK
    Biochem J; 1985 May; 227(3):767-75. PubMed ID: 4004798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
    Moya-Camarena SY; Van den Heuvel JP; Belury MA
    Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
    Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
    Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of covalent binding of peroxisome proliferators nafenopin and Wy-14 643 to DNA in vivo and in vitro.
    Goel SK; Lalwani ND; Fahl WE; Reddy JK
    Toxicol Lett; 1985 Jan; 24(1):37-43. PubMed ID: 2579476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
    Cai Y; Appelkvist EL; DePierre JW
    J Biochem Toxicol; 1995 Apr; 10(2):87-94. PubMed ID: 7562957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
    Eacho PI; Lanier TL; Brodhecker CA
    Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
    Tomaszewski KE; Agarwal DK; Melnick RL
    Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
    Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.